LifeStance Health Group, Inc. (NASDAQ:LFST) Given Average Recommendation of “Moderate Buy” by Analysts

Shares of LifeStance Health Group, Inc. (NASDAQ:LFST) have received an average recommendation of “Moderate Buy” from the nine analysts that are covering the firm, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, one has issued a hold recommendation, six have issued a buy recommendation and one has assigned a strong buy recommendation to the company. The average 12 month price objective among brokerages that have issued ratings on the stock in the last year is $9.00.

A number of research firms recently weighed in on LFST. BMO Capital Markets began coverage on LifeStance Health Group in a report on Thursday, November 13th. They issued an “outperform” rating and a $8.00 price target on the stock. BTIG Research boosted their target price on LifeStance Health Group from $8.00 to $9.00 and gave the stock a “buy” rating in a research report on Thursday, November 6th. Weiss Ratings reissued a “sell (d-)” rating on shares of LifeStance Health Group in a report on Monday, December 1st. Wall Street Zen downgraded LifeStance Health Group from a “buy” rating to a “hold” rating in a research note on Saturday, October 11th. Finally, UBS Group boosted their price objective on shares of LifeStance Health Group from $9.00 to $10.00 and gave the stock a “buy” rating in a research report on Friday, November 7th.

LifeStance Health Group Stock Performance

NASDAQ:LFST opened at $6.41 on Tuesday. The firm’s fifty day simple moving average is $5.74 and its 200-day simple moving average is $5.30. The company has a quick ratio of 1.58, a current ratio of 1.58 and a debt-to-equity ratio of 0.18. The stock has a market cap of $2.49 billion, a PE ratio of -213.67 and a beta of 1.12. LifeStance Health Group has a fifty-two week low of $3.74 and a fifty-two week high of $8.30.

LifeStance Health Group (NASDAQ:LFST) last released its quarterly earnings data on Wednesday, November 5th. The company reported $0.02 EPS for the quarter, topping analysts’ consensus estimates of ($0.01) by $0.03. LifeStance Health Group had a negative net margin of 0.67% and a negative return on equity of 0.62%. The firm had revenue of $363.81 million for the quarter, compared to the consensus estimate of $355.06 million. During the same quarter in the previous year, the firm earned ($0.02) earnings per share. The firm’s revenue was up 16.3% on a year-over-year basis. Analysts expect that LifeStance Health Group will post -0.18 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Lisa K. Miller sold 57,240 shares of the stock in a transaction that occurred on Friday, November 21st. The shares were sold at an average price of $6.43, for a total value of $368,053.20. Following the sale, the insider directly owned 261,292 shares in the company, valued at $1,680,107.56. This represents a 17.97% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. 6.60% of the stock is owned by company insiders.

Hedge Funds Weigh In On LifeStance Health Group

A number of institutional investors have recently modified their holdings of the company. Bayesian Capital Management LP acquired a new stake in LifeStance Health Group during the second quarter worth approximately $52,000. Park Edge Advisors LLC purchased a new position in shares of LifeStance Health Group during the 2nd quarter worth $52,000. Vanguard Personalized Indexing Management LLC acquired a new stake in shares of LifeStance Health Group during the third quarter worth $72,000. Blair William & Co. IL purchased a new stake in shares of LifeStance Health Group in the second quarter valued at $70,000. Finally, Public Employees Retirement System of Ohio acquired a new position in LifeStance Health Group in the second quarter valued at $70,000. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Company Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.